UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Markers of and Risk Factors for the Development and Progression of Diabetic Kidney Disease

American journal of kidney diseases, 2014-02, Vol.63 (2), p.S39-S62

2014

Volltextzugriff (PDF)

Clinical predictive factors in diabetic kidney disease progression

Journal of diabetes investigation, 2017-01, Vol.8 (1), p.6-18

2017

Volltextzugriff (PDF)

Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy

Diabetes (New York, N.Y.), 2012-12, Vol.61 (12), p.3304-3313

2012

Volltextzugriff (PDF)

Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides

Journal of the American Society of Nephrology, 2015-08, Vol.26 (8), p.1999-2010

2015

Volltextzugriff (PDF)

Effects of glycaemic management on diabetic kidney disease

World journal of diabetes, 2017-05, Vol.8 (5), p.172-186

2017

Volltextzugriff (PDF)

Sodium and Its Role in Cardiovascular Disease - The Debate Continues

Frontiers in endocrinology (Lausanne), 2016-12, Vol.7, p.164-164

2016

Volltextzugriff (PDF)

Nonalbuminuric Renal Impairment in Type 2 Diabetic Patients and in the General Population (National Evaluation of the Frequency of Renal Impairment cO-existing with NIDDM [NEFRON] 11)

Diabetes care, 2009-08, Vol.32 (8), p.1497-1502

2009

Volltextzugriff (PDF)

Chronic kidney disease and measurement of albuminuria or proteinuria: a position statement

Medical journal of Australia, 2012-08, Vol.197 (4), p.224-225

2012

Volltextzugriff (PDF)

Nonalbuminuric Renal Insufficiency in Type 2 Diabetes

Diabetes care, 2004-01, Vol.27 (1), p.195-200

2004

Volltextzugriff (PDF)

Use of Readily Accessible Inflammatory Markers to Predict Diabetic Kidney Disease

Frontiers in endocrinology (Lausanne), 2018-05, Vol.9, p.225-225

2018

Volltextzugriff (PDF)

Intensive Glucose Control and Cardiovascular Outcomes in Type 2 Diabetes

Heart, lung & circulation, 2011-10, Vol.20 (10), p.647-654

2011

Volltextzugriff (PDF)

Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes

Journal of diabetes investigation, 2019-11, Vol.10 (6), p.1537-1542

2019

Volltextzugriff (PDF)

Effect of Resistance Training on Functional Capacity and Quality of Life in Individuals with High and Low Numbers of Metabolic Risk Factors

Diabetes care, 2007-09, Vol.30 (9), p.2205-2210

2007

Volltextzugriff (PDF)

Three Dimensional Glomerular Reconstruction: A Novel Approach to Evaluate Renal Microanatomy in Diabetic Kidney Disease

Scientific reports, 2019-02, Vol.9 (1), p.1829-1829, Article 1829

2019

Volltextzugriff (PDF)

Integrating albuminuria and GFR in the assessment of diabetic nephropathy

Nature reviews. Nephrology, 2009-07, Vol.5 (7), p.397-406

2009

Volltextzugriff (PDF)

Serial Measurements of Cystatin C Are More Accurate Than Creatinine-Based Methods in Detecting Declining Renal Function in Type 1 Diabetes

Diabetes care, 2008-05, Vol.31 (5), p.971-973

2008

Volltextzugriff (PDF)

Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)

The Journal of clinical investigation, 2001-12, Vol.108 (12), p.1853-1863

2001

Volltextzugriff (PDF)

BDNF, Metabolic Risk Factors, and Resistance Training in Middle-Aged Individuals

Medicine and science in sports and exercise, 2008-03, Vol.40 (3), p.535-541

2008

Volltextzugriff (PDF)

Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy

Journal of the American Society of Nephrology, 2005-08, Vol.16 (8), p.2363-2372

2005

Volltextzugriff (PDF)

Long-term intra-individual variability of albuminuria in type 2 diabetes mellitus: implications for categorization of albumin excretion rate

BMC nephrology, 2017-12, Vol.18 (1), p.355-9, Article 355

2017

Volltextzugriff (PDF)

Effects and clinical potential of very-low-calorie diets (VLCDs) in type 2 diabetes

Diabetes research and clinical practice, 2009-09, Vol.85 (3), p.235-242

2009

Volltextzugriff (PDF)

Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events in Diabetic Nephropathy?

Current drug targets, 2016-09, Vol.17 (11), p.1252-1264

2016

Volltextzugriff (PDF)

Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy

Kidney international, 2010-08, Vol.78 (3), p.287-295

2010

Volltextzugriff (PDF)

Reduction of the Accumulation of Advanced Glycation End Products by ACE Inhibition in Experimental Diabetic Nephropathy

Diabetes (New York, N.Y.), 2002-11, Vol.51 (11), p.3274-3282

2002

Volltextzugriff (PDF)

Effects of Salt Supplementation on the Albuminuric Response to Telmisartan With or Without Hydrochlorothiazide Therapy in Hypertensive Patients With Type 2 Diabetes Are Modulated by Habitual Dietary Salt Intake

Diabetes care, 2009-08, Vol.32 (8), p.1398-1403

2009

Volltextzugriff (PDF)

1 – 25 von 270

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(255)
Mit Volltextzugriff
(222)

Publikationsform

Sprache

Englisch
(270)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(184)
Life Sciences & Biomedicine
(182)
Humans
(146)
Male
(137)
Female
(100)
Biological And Medical Sciences
(95)
Medical Sciences
(93)
Middle Aged
(78)
Diabetes
(77)
Endocrinology & Metabolism
(64)
Adult
(62)
Aged
(55)
Endocrinopathies
(55)
Animals
(52)
Endocrine Pancreas. Apud Cells
(52)
Diabetes. Impaired Glucose Tolerance
(50)
Urology & Nephrology
(46)
Glomerular Filtration Rate
(43)
Rats
(42)
Blood Pressure
(36)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Markers of and Risk Factors for the Development and Progression of Diabetic Kidney Disease

Clinical predictive factors in diabetic kidney disease progression

Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy

Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides

Effects of glycaemic management on diabetic kidney disease

Sodium and Its Role in Cardiovascular Disease - The Debate Continues

Nonalbuminuric Renal Impairment in Type 2 Diabetic Patients and in the General Population (National Evaluation of the Frequency of Renal Impairment cO-existing with NIDDM [NEFRON] 11)

Chronic kidney disease and measurement of albuminuria or proteinuria: a position statement

Nonalbuminuric Renal Insufficiency in Type 2 Diabetes

Use of Readily Accessible Inflammatory Markers to Predict Diabetic Kidney Disease

Intensive Glucose Control and Cardiovascular Outcomes in Type 2 Diabetes

Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes

Effect of Resistance Training on Functional Capacity and Quality of Life in Individuals with High and Low Numbers of Metabolic Risk Factors

Three Dimensional Glomerular Reconstruction: A Novel Approach to Evaluate Renal Microanatomy in Diabetic Kidney Disease

Integrating albuminuria and GFR in the assessment of diabetic nephropathy

Serial Measurements of Cystatin C Are More Accurate Than Creatinine-Based Methods in Detecting Declining Renal Function in Type 1 Diabetes

Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)

BDNF, Metabolic Risk Factors, and Resistance Training in Middle-Aged Individuals

Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy

Long-term intra-individual variability of albuminuria in type 2 diabetes mellitus: implications for categorization of albumin excretion rate

Effects and clinical potential of very-low-calorie diets (VLCDs) in type 2 diabetes

Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events in Diabetic Nephropathy?

Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy

Reduction of the Accumulation of Advanced Glycation End Products by ACE Inhibition in Experimental Diabetic Nephropathy

Effects of Salt Supplementation on the Albuminuric Response to Telmisartan With or Without Hydrochlorothiazide Therapy in Hypertensive Patients With Type 2 Diabetes Are Modulated by Habitual Dietary Salt Intake

Suchergebnisse filtern